Staar Tackles Compliance Issues; AMO Sets Sights On Overseas Lens Market
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical will create a dedicated compliance office as part of an operational restructuring to boost its regulatory standing in the wake of two warning letters issued by FDA since December